|
|
| | 2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidin-5-yl)acetic acid Basic information |
| Product Name: | 2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidin-5-yl)acetic acid | | Synonyms: | 2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidin-5-yl)acetic acid;2-Butyl-1,6-dihydro-4-methyl-6-oxo-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetic acid;2-Butyl-1,6-dihydro-4-methyl-6-oxo-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineacetic Acid;2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidi;2-(1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)acetic acid;5-Pyrimidineacetic acid, 2-butyl-1,6-dihydro-4-methyl-6-oxo-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- | | CAS: | 178554-16-0 | | MF: | C25H26N6O3 | | MW: | 458.51 | | EINECS: | | | Product Categories: | | | Mol File: | 178554-16-0.mol | ![2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidin-5-yl)acetic acid Structure](CAS/20150408/GIF/178554-16-0.gif) |
| | 2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidin-5-yl)acetic acid Chemical Properties |
| Boiling point | 717.0±70.0 °C | | density | 1.32±0.1 g/cm3(Predicted) | | pka | 3.88±0.10(Predicted) |
| | 2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidin-5-yl)acetic acid Usage And Synthesis |
| Uses | 2-Butyl-1,6-dihydro-4-methyl-6-oxo-1-[[2''-(2H-tetrazol-5-yl)[1,1''-biphenyl]-4-yl]methyl]-5-pyrimidineacetic Acid can be used for the characterization of metabolites in human liver microsomes and plasma using quantitative and qualitative analysis. It can also be used for synthesis and antagonists for angiotensin II receptor type 1 (AT1) and for anti-hypertensive activity of pyrimidin-4(3H)-one losartan analogs. |
| | 2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-2-butyl-4-Methyl-6-oxo-1,6-dihydropyriMidin-5-yl)acetic acid Preparation Products And Raw materials |
|